Grifols | GRFS - Passività Correnti





Passività Correnti Cambiamento Data
Alaunos Therapeutics USD 921K 153K 2025-09
Arca Biopharma USD 20.97M 8.86M 2025-09
aTyr Pharma USD 15.68M 148K 2025-09
Bio Path USD 7.86M 3.12M 2025-06
Brainstorm Cell Therapeutics USD 9.02M 495K 2025-09
Capricor Therapeutics USD 28.15M 249K 2025-09
Cara Therapeutics USD 10.68M 9.48M 2025-06
Esperion Therapeutics USD 300.81M 58.22M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Immunic USD 30.08M 2.77M 2025-09
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
TherapeuticsMD USD 5.82M 655K 2024-06